Affordable Care Act subsidies set to expire, impacting some Covered California premiums

Federal Affordable Care Act premium tax credits are set to expire at midnight, which KFF estimates could raise premiums by an average of 114%, with larger impacts for near-retirees and higher-income consumers. California has earmarked $190 million for 2026 to blunt the effect for Covered California enrollees (more than 1.9 million people), preserving 2025 premium levels for households with incomes up to $23,475 (individual) or $48,225 (family of four); still, officials warn up to 400,000 Californians could become uninsured. The deadline for coverage in January is Dec. 31 (open enrollment for 2026 ends Jan. 31), and the lapse occurs amid continuing federal funding and shutdown uncertainty that could prolong policy risk.

Analysis

Market structure: The immediate winners are large, diversified payers and PBM-integrated players (UnitedHealth UNH, Elevance ELV, CVS Health CVS) who can reprice or absorb individual-market churn; losers are exchange-heavy insurers and small-cap managed-care names (Centene CNC, Molina MOH) and community hospitals (HCA) facing higher uncompensated care. A potential 114% average premium shock and CA’s estimate of up to 400k newly uninsured will compress demand for elective care, shift pricing power to incumbents, and likely force rate increases or market exits among weaker exchange carriers over 1–4 quarters.

Risk assessment: Tail risk is a prolonged federal non-extension of subsidies combined with another shutdown, producing >20% enrollment loss and widespread state bailouts; secondary effects include state budget strain and widening insurer loss ratios. Key horizons: immediate (Dec 31–Jan 31 open enrollment reaction), short-term (Q1 2026 enrollment/earnings), medium (insurer rate filings for 2027) and long-term (legislative resolution mid-2026). Catalysts: congressional roll-call, weekly CA enrollment updates, and insurer guidance/filings.

Trade implications: Enter relative-value overweight on UNH/ELV/CVS vs underweight CNC/MOH; use 4–12 week tactical puts on exchange-focused names and 3–9 month call spreads on diversified payers to play pricing consolidation. Reduce exposure to hospital-centric equities and healthcare REITs with large charity-care footprints; consider credit protection on smaller insurers if CDS liquidity allows, and size initial positions 1.5–3% each with stop losses at 6–8%.

Contrarian angles: The market may overprice near-term enrollment pain—CA’s $190M bridge and likely state stopgaps mean worst-case attrition may be <50% of the 400k estimate. Survivors could enjoy higher unit economics and M&A; historical precedent (post-2017 repeal scares) shows enrollment shocks can re-concentrate markets and lift large-cap margins within 6–12 months. Monitor for accelerated consolidation as the asymmetric opportunity.

Key Decisions for Investors

• Establish a 2–3% portfolio LONG in UnitedHealth (UNH) or Elevance (ELV) split (e.g., 1.5% UNH, 1.5% ELV) via stock or 6–9 month bull call spreads ahead of Q1 2026 earnings—diversified payers should capture pricing power as smaller exchange players retreat.
• Establish a 1.5–2% portfolio SHORT in Centene (CNC) and 1% SHORT in Molina (MOH) via 3-month put spreads (limit risk) sized to equal dollar exposure to the long payer position; add more if weekly CA enrollment falls >5% MoM or company guidance is cut.
• Buy a tactical hedge: 90-day put spread (buy 25-delta, sell 10-delta) on MOH sized 0.5–1% of portfolio to protect against rapid enrollment deterioration between now and Jan 31 open enrollment close.
• Reduce direct hospital/hospital-REIT exposure by 30–50% vs benchmark weight (e.g., trim HCA, WELL, or similar) and redeploy into large-cap payers and PBMs (CVS) over the next 2–8 weeks; reassess after Q1 2026 enrollment and state subsidy announcements.